セッション詳細
[WS(P)19]Tolerance and immune suppression focusing on regulatory T cell biology
2024年12月4日(水) 16:40 〜 17:25
Poster 4
[WS19-01-O/P]Runx3/Cbfβ is required for differentiation and function of Thetis APCs that drives Rorγt+ pTreg differentiation
○Chihiro Ogawa, Ichiro Taniuchi (RIKEN Center for Integrative Medical Sciences, Laboratory for Transcriptional Regulation)
[WS19-02-O/P]Foxp3 corporates with NFκB to promote endogenous Foxp3 transcription in vivo
○Yuxi Wei, Akira Nakajima, Shohei Hori (Laboratory of Immunology and Microbiology, Graduate School of Pharmaceutical Sciences, The University of Tokyo)
[WS19-03-O/P]Possible diversity of Treg cell development pathways branching from CD25negFoxp3neg pre-precursor stage in the thymus
○Ryoji Kawakami1,2, Shimon Sakaguchi1,2 (1.Institute for Life and Medical Sciences (LiME), Kyoto University, 2.Immunology Frontier Research Center (IFReC), Osaka University)
[WS19-04-O/P]Generation and activation of naturally arising memory-phenotype CD4+ T lymphocytes are homeostatically restricted by regulatory T cells dependently of TCR, CD28, and IL-2 signaling
○Jing Li, Ziying Yang, Akihisa Kawajiri, Kosuke Sato, Shunichi Tayama, Naoto Ishii, Takeshi Kawabe (Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine)
[WS19-05-O/P]Characterization of peripheral blood Treg cells
○Takashi Sekiya (Department of Immune regulation, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine)
[WS19-06-O/P]CD80/CD86-CD28 signal blockade during the mixed lymphocyte reaction augments the alloantigen-specific inhibitory function of natural regulatory T cells
○Kyoko Yogo1,3, Kazuyoshi Takeda1, Ko Okumura1, Ryuichi Murakami2, Shohei Hori2, Koichiro Uchida1 (1.Center for Immunotherapy and Diagnosis, Juntendo University, 2.Laboratory of Immunology and Microbiology, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 3.JUNTEN BIO Co., Ltd.)
[WS19-07-O/P]Induction of antigen-specific Treg in vivo with mRNA
○Shota Imai1, Tomoyoshi Yamano1,2, Rikinari Hanayama1,2 (1.Department of Immunology, Graduate School of Medicine Kanazawa University, 2.WPI Nano Life Science Institute (NanoLSI), Kanazawa university)
[WS19-08-P]Polyclonal iTreg mediate Target Specific Suppression
○Yoshihiro Oya1,2, Takuya Nakazawa2, Ryutaro Matsumura2, Hiroshi Nakajima3, Ethan M Shevach4 (1.Laboratory of Autoimmune diseases, National Hospital Organization(NHO) Chibahigashi National Hospital, 2.Allergy & Clinical Immunology, National Hospital Organization Chibahigashi National Hospital, 3.Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 4.Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health)
[WS19-09-P]An endogenous lipid in human plasmais a potential immunosuppressant
○Shigenari Ishizuka1,2, Yasunobu Miyake2, Hiroki Yoshida2, Sho Yamasaki1,3,4 (1.Department of Molecular Immunology, Research Institute for Microbial Diseases (RIMD), Osaka University, 2.Division of Molecular and Cellular Immunoscience, Department of Biomolecular Sciences, Faculty of Medicine, Saga University, 3.Laboratory of Molecular Immunology, Immunology Frontier Research Center (IFReC), Osaka University, 4.Center for Infectious Disease Education and Research (CiDER), Osaka University)
[WS19-10-P]Dimer formation and ligand recognition of secreted receptor LILRA3
○Shinsuke Imai1, Hiroshi Watanabe1, Kimiko Kuroki1, Katsumi Maenaka1,2,3,4,5 (1.Faculty of Pharmaceutical Scienced, Hokkaido University, 2.Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, 3.Hokkaido University International Institute for Zoonosis Control, 4.Research and Development (HU-IVReD), Hokkaido University, 5.Faculty of Pharmaceutical Scienced, Kyusyu University)
[WS19-11-P]Functional defect in regulatory CD4+ T cells in a novel inflammatory bowel disease model
○Hideki Ogura1, Soutaro Hanawa2, Akie Teratani1, Ryo Unita3, Satoshi Ishido1 (1.Department of Microbiology, Hyogo Medical University, 2.Department of Oral and Maxillofacial Surgery, Hyogo Medical University, 3.Department of Emergency and Critical Care Medicine, Hyogo Medical University)
[WS19-12-P]Differentiation of peripherally-derived Treg cells and restoration of oral tolerance by food intake and costimulatory blockade
○Masaya Arai1, Ryoji Kawakami2, Yamami Nakamura1, Yoko Naito3, Daisuke Motooka3, Norihisa Mikami1, Shimon Sakaguchi1,2 (1.Department of Experimental Immunology, IFReC, Osaka University, 2.Department of Experimental Immunology, LiMe, Kyoto University, 3.Genome Information Research Center, RIMD, Osaka University)
[WS19-13-P]ILDR2+CD206+ macrophages in the sublingual mucosa potentially induce regulatory T cells.
○Farzana Sultana, Miyuki Azuma, Shigenori Nagai (Molecular Immunology)
[WS19-14-P]Balancing Treg and exTreg dynamics via CTCF-mediated chromatin organization controls autoimmune diseases and immunotherapy outcomes
○Ying ying Zhou1, Li Qiu2, Yuan Hui2,3, Sheng bao Suo4,5, Guang shuai Jia3, Qi bin Leng2 (1.Guangzhou Medical University, 2.Guangzhou Institute of Cancer Research, State Key Laboratory of Respiratory Disease, Guangzhou Medical University, 3.State Key Laboratory of Respiratory Disease, GMU-GIBH Joint School of Life Sciences, Guangzhou Medical University, 4.Guangzhou Laboratory-Guangzhou Medical University, 5.The First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease)
[WS19-15-P]Non-specific Symmetric Control is Crucial for Autonomous Optimization of Immune Balance
○Tomoyuki Yamaguchi (Basic Immunology, Research Institute, Nozaki Tokushukai Hospital)